nfdi4health aims to create the most comprehensive inventory of German epidemiological, public health and clinical trial data to date. It builds a centralised data catalogue with elaborate search functionalities, sophisticated data access management, and a data analysis toolbox, while respecting stringent requirements for privacy concerning personal health data. Standardisation services ensure a high degree of interoperability. Use cases covering prototypical study types and areas of research show the feasibility of a harmonised implementation of all infrastructures, tools and services in accordance with the user communities.
Web page: https://www.nfdi4health.de
Funding details:Funding for nfdi4health is granted by the DFG - Deutsche Forschungsgemeinschaft (German Research Foundation). In support of the establishment and promotion of all research data infrastructures, both the German Federal Government and individual states together intend to provide up to EUR 90 million annually (via DFG), with the intention to create a long-term sustained platform supporting research.
Related items
- People (46)
- Projects (2)
- Institutions (12)
- Investigations (13+3)
- Studies (14+3)
- Assays (5+9)
- Data files (9+12)
- Publications (3)
- Presentations (0+6)
- Events (0+8)
- Documents (7+25)
Projects: WG Infrastructure for Translational Research, GMDS Project Group "FAIRe Dateninfrastrukturen für die Biomedizinische Informatik", FAIRDOM user meeting, COVID-19 related studies and tools in Germany, nfdi4health - German National Research Data Infrastructure for Personal Health Data
Institutions: University Medical Center Göttingen
Projects: COVID-19 related studies and tools in Germany, nfdi4health - German National Research Data Infrastructure for Personal Health Data
Institutions: ZB MED - Information Centre for Life Sciences
https://orcid.org/0000-0001-5246-9351Expertise: Data Management, Databases, Dynamic modelling, Ontology
Tools: Data Management, Java, semantic web, linux, sparql, Jena
Projects: nfdi4health - German National Research Data Infrastructure for Personal Health Data
Institutions: University of Cologne
https://orcid.org/0000-0002-2140-4616Expertise: Public Health
Tools: Data Management
Christin is a project manager at DOCYET. She has a degree in social work, public health and medical ethics. In addition to her full-time professional work, she is a PhD candidate at the University of Bremen. She has training and certificates in data stewardship, project & change & hospital management. The following research and application areas fascinate her mostly: health-related data/infrastructure, FAIRification, robotics in medicine, health standards and digital health solutions.
Projects: FAIRDOM, Early Metabolic Injury (LiSyM-EMI - Pillar I), Chronic Liver Disease Progression (LiSyM-DP - Pillar II), Regeneration and Repair in Acute-on-Chronic Liver Failure (LiSyM-ACLF - Pillar III), LiSyM Core Infrastructure and Management (LiSyM-PD), Liver Function Diagnostics (LiSyM-LiFuDi - Pillar IV), Model Guided Pharmacotherapy In Chronic Liver Disease (LiSyM-MGP), Multi-Scale Models for Personalized Liver Function Tests (LiSyM-MM-PLF), The Hedgehog Signalling Pathway (LiSyM-JGMMS), Molecular Steatosis - Imaging & Modeling (LiSyM-MSIM), Kinetics on the move - Workshop 2016, Example use cases, FAIRDOM user meeting, MS_DILI, COMBINE Multicellular Modelling, FAIRDOM & LiSyM & de.NBI Data Structuring Training, EnzymeML, GMDS Project Group "FAIRe Dateninfrastrukturen für die Biomedizinische Informatik", FAIRDOM Community Workers, COVID-19 Disease Map, COVID-19 related studies and tools in Germany, nfdi4health - German National Research Data Infrastructure for Personal Health Data, ModeleXchange initiative, SDBV/HITS, EDITH (Ecosystem Digital Twins in Health) test project
Institutions: Heidelberg Institute for Theoretical Studies (HITS gGmbH)
https://orcid.org/0000-0002-8683-7084Data management and standardization expert for systems biology and systems medicine, responsible for the data management user requirements and user contacts within the German LiSyM network (Liver Systems Medicine: http://lisym.org/) and associated to the FAIRDOM team. Involved in different standardization initiatives and committees, i.e. COMBINE (http://co.mbine.org), ISO/TC 276 Biotechnology (https://www.iso.org/committee/4514241.html), European COST action CHARME (http://www.cost-charme.eu) and ...
Projects: FAIRDOM, GMDS Project Group "FAIRe Dateninfrastrukturen für die Biomedizinische Informatik", COVID-19 Disease Map, COVID-19 related studies and tools in Germany, nfdi4health - German National Research Data Infrastructure for Personal Health Data, LiSyM Core Infrastructure and Management (LiSyM-PD), ModeleXchange initiative, SDBV/HITS, EDITH (Ecosystem Digital Twins in Health) test project
Institutions: Heidelberg Institute for Theoretical Studies (HITS gGmbH)
https://orcid.org/0000-0002-8318-3222nfdi4health aims to create the most comprehensive inventory of German epidemiological, public health and clinical trial data to date. It builds a centralised data catalogue with elaborate search functionalities, sophisticated data access management, and a data analysis toolbox, while respecting stringent requirements for privacy concerning personal health data. Standardisation services ensure a high degree of interoperability. Use cases covering prototypical study types and areas of research show ...
Programme: nfdi4health - German National Research Data Infrastructure for Personal Health Data
Public web page: https://www.nfdi4health.de
Start date: 1st Jul 2020
Organisms: Homo sapiens
This project bundles information about COVID-19 related studies and tools in Germany. It intends to provide an information hub for the different initiatives, their aims, their processes, standards and study protocols, as well as their available data and metadata. It is initiated by the German National Research Data Infrastructure for Personal Health Data (nfdi4health), a consortium that plans to establish a concept for a federated research data infrastructure for personal health data in Germany. ...
Country: Germany
City: Berlin
Web page: https://www.bihealth.org/en/research/core-facilities/interoperability/
Country: Germany
City: Magdeburg
TA3 focusses on the services, service enabling tools, and software that NFDI4Health will provide to the user community. Most services and tools will be based on open source software that has already been developed by the (co-)applicants or by the broader scientific developer community. In close cooperation with TA4 and TA5, use case requirements and community feedback will help to further develop these tools and to foster interoperability of currently fragmented IT solutions for storage of metadata, ...
Snapshots: No snapshots
nfdi4health Dokumente und (interne) Daten, SOPs, etc., die relevant für das gesamte Konsortium sind
Snapshots: No snapshots
Key activities of TA1 concern the establishment of functional bodies and of the project governance for NFDI4Health.
Snapshots: No snapshots
NFDI4Health task area 2 targets core deficits in medical sciences, i.e. the lack of harmonised standards for data and data quality management in clinical trials, public health surveys, and epidemiological cohorts, as well as the lack of information on and access to relevant standards. By making standards available, TA2 will improve the findability, accessibility and interoperability of existing and novel data bodies. For this purpose, guidelines, standards and policies on data management and ...
Submitter: Martin Golebiewski
Studies: NFDI4Health T2.1: Data management and publication policies, NFDI4Health T2.2: Data and metadata standards and integration, NFDI4Health T2.3: Data quality and data provenance, NFDI4Health T2.4: Standardisation of health data access and interoperabi...
Assays: No Assays
Snapshots: No snapshots
With its focus on interaction, networking and exchange, task area 4 addresses the overall NFDI4Health Key Objective to support cooperation between clinical research, epidemiological and public health communities. It also provides training and education for the health research community and beyond, focusing on FAIR data principles.
Shared Space on OneDrive: https://onedrive.live.com/?id=4E57D2DCFD31954C%213715&cid=4E57D2DCFD31954C
Snapshots: No snapshots
The main objective of task area 5 of NFDI4Health is to implement or to at least explore the possibilities to implement these infrastructure components in specific use cases which reflect core needs of the scientific community related to health data research. The use cases will address a range of areas which will lay the ground for future expansion for full coverage of the broad range of data collected in health research.
Snapshots: No snapshots
Data protection regulations have to be taken into account on many levels of the infrastructure developed by NFDI4Health. Moreover, the health data managed by NFDI4Health belong to the so-called special categories of personal data, the processing of which is subject to particularly strict data protection requirements. But nevertheless, data protection law contains a variety of regulatory approaches of data processing for scientific research purposes, which are all aimed at a privileged treatment ...
Snapshots: No snapshots
Consortium website: https://covidclinical.net/
Slack: https://c19i2b2.slack.com/ Owner: Nils Gehlenborg (nils@hms.harvard.edu)
i2b2 tranSMART Foundation Call to Action: https://transmartfoundation.org/covid-19-call-to-action/
Submitter: Harald Kusch
Studies: General Information, Phase 1, Phase 1.1, Phase 2
Assays: Chats, Instructions, Websites
Snapshots: No snapshots
Snapshots: No snapshots
Submitter: Matthias Löbe
Studies: Entwicklung eines Tests zum Nachweis der Immunantwort bei Covid-19 (CoV2...
Assays: No Assays
Snapshots: No snapshots
Die Charité – Universitätsmedizin Berlin betreibt gemeinsam mit dem Berlin Institute of Health Clinical Study Center (BIH-CSC) eine zentrale Registerstudie ("Pa-COVID-19") und Phänotypisierungs- plattform für alle an der Charité behandelten Patienten mit COVID-19. Pa-COVID-19 dient der harmonisierten und standardisierten klinischen und molekularen Phänotypisierung von COVID-19 Patienten. Übergeordnetes Ziel ist die schnelle und umfassende Charakterisierung von COVID-19 zur Identifikation von ...
Snapshots: No snapshots
Snapshots: No snapshots
Collection of cross-links to other sites that gather COVID-19 information
Submitter: Harald Kusch
Studies: University Medical Center Göttingen, ZB MED – Informationszentrum Lebenswissenschaften
Assays: COVI-19 Übersicht
Snapshots: No snapshots
To achieve data “FAIRification by standardisation” and enable the user community to integrate heterogeneous and complex data, recommendations and guidelines will be developed for the consistent use of domain-specific standards for data formats, as well as for consistent data descriptions based on established metadata standards and terminologies. This standardisation concept will be based on existing standards, such as ISO 20691 and will include the definition of a minimal metadata set for ...
Snapshots: No snapshots
This task T2.3 will target data quality as the “degree to which a set of inherent characteristics of data fulfils requirements” and provide consented standards and metrics to assess the data quality at different stages of the scientific data lifecycle. (1) It will first consider FAIR standards in collaboration with the FAIRMetrics group, FAIRsharing, and RDA FAIR Data Maturity Model group. (2) The second focus will be on adherence to defined data and metadata standards as recommended by nfdi4health ...
Snapshots: No snapshots
T2.4 will define standardisation requirements and develop guidelines, as well as standard-based solutions for data access and interoperability in the defined use cases. To ensure compatibility with existing efforts aiming to improve data interoperability in medicine and healthcare, T2.4 also will coordinate its work closely with the same standardisation initiatives and technical committees of standardisation organisations as T2.2. To enable a seamless access and exchange of health data within the ...
Snapshots: No snapshots
This task aims for policies for data management and publication in order to make data of public health studies findable and interoperable. To find information about studies and (meta-)data and to ensure their interoperability, it is necessary to document the descriptive core elements in a structured way already when planning projects. This applies both to data management and to the subsequent publication of research results and data and is particularly important for research projects handling ...
Snapshots: No snapshots
Submitter: Theresa Bender
Investigation: Consortium for Clinical Characterization of COV...
Assays: No Assays
Snapshots: No snapshots
Submitter: Theresa Bender
Investigation: Consortium for Clinical Characterization of COV...
Assays: No Assays
Snapshots: No snapshots
Submitter: Theresa Bender
Investigation: Consortium for Clinical Characterization of COV...
Assays: Instructions
Snapshots: No snapshots
Submitter: Matthias Löbe
Investigation: Lean European Open Survey on SARS-CoV-2 Infecte...
Assays: LEOSS Clinical Document List
Snapshots: No snapshots
Eine diagnostische Studie der Stufe 1 zur Entwicklung des SARS-CoV-2-ELISA. Ziel der Studie ist die Bestimmung von Sensitivität und Spezifität des Tests bei Probanden mit bekannter Erkrankung und bei Kontrollpersonen.
https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021166
Snapshots: No snapshots
Submitter: Ulrich Sax
Investigation: Lean European Open Survey on SARS-CoV-2 Infecte...
Assays: No Assays
Snapshots: No snapshots
Submitter: Ulrich Sax
Investigation: Lean European Open Survey on SARS-CoV-2 Infecte...
Assays: No Assays
Snapshots: No snapshots
Submitter: Theresa Bender
Investigation: Consortium for Clinical Characterization of COV...
Snapshots: No snapshots
Submitter: Harald Kusch
Investigation: Further information collections on COVID-19
Assays: COVI-19 Übersicht
Snapshots: No snapshots
Submitter: Harald Kusch
Investigation: Further information collections on COVID-19
Assays: No Assays
Snapshots: No snapshots
Submitter: Harald Kusch
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Further information collections on COVID-19
Organisms: No organisms
SOPs: No SOPs
Data files: ZBMED-COVID-19-Übersicht (URL)
Snapshots: No snapshots
Submitter: Theresa Bender
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Consortium for Clinical Characterization of COV...
Study: General Information
Organisms: No organisms
SOPs: No SOPs
Data files: No Data files
Snapshots: No snapshots
Submitter: Theresa Bender
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Consortium for Clinical Characterization of COV...
Study: General Information
Organisms: No organisms
SOPs: No SOPs
Data files: No Data files
Snapshots: No snapshots
Submitter: Theresa Bender
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Consortium for Clinical Characterization of COV...
Study: Phase 1
Submitter: Matthias Löbe
Assay type: Experimental Assay Type
Technology type: Clinical Document
Investigation: Lean European Open Survey on SARS-CoV-2 Infecte...
Study: LEOSS
Organisms: No organisms
SOPs: No SOPs
Data files: No Data files
Snapshots: No snapshots
The NFDI4Health Task Force COVID-19 Metadata Schema (MDS) Mapping to FHIR contains a list of properties describing a resource (study, questionnaire or document) being registered in the Central Search Hub of the NFDI4Health Task Force COVID-19 and their mapping to FHIR.
Creators: Sophie Klopfenstein, Aliaksandra Shutsko, Moritz Lehne, Matthias Löbe, Carsten Oliver Schmidt, Carina Vorisek, Julian Sass, Sylvia Thun
Submitter: Sophie Klopfenstein
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
The NFDI4Health Task Force COVID-19 Metadata Schema Mapping (Metadata Schema Mapping) contains a list of properties describing a resource being registered in the Study Hub of the NFDI4Health Task Force COVID-19 (Study Hub) and how those properties align with other standards (FHIRE, CDISK, DRKS, ITRCP)
Creators: None
Submitter: Martin Golebiewski
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
The NFDI4Health Task Force COVID-19 Metadata Schema (Metadata Schema) contains a list of properties describing a resource being registered in the Study Hub of the NFDI4Health Task Force COVID-19 (Study Hub).
Creators: Aliaksandra Shutsko, Carsten Oliver Schmidt, Johannes Darms, Martin Golebiewski, Moritz Lehne, Matthias Löbe, Sophie Klopfenstein, Carina Nina Vorisek
Submitter: Martin Golebiewski
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
First selection of LOINC Codes for data extraction
Creators: Theresa Bender, Christian Bauer
Submitter: Theresa Bender
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Instructions and database scripts for extracting COVID-19 related data from i2b2
Creators: Theresa Bender, Christian Bauer
Submitter: Theresa Bender
Investigations: Consortium for Clinical Characterization of COV...
Studies: Phase 1
Assays: Instructions
Creators: Theresa Bender, Christian Bauer
Submitter: Theresa Bender
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Owner: Nils Gehlenborg (nils@hms.harvard.edu)
Creators: Theresa Bender, Christian Bauer
Submitter: Theresa Bender
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Harald Kusch
Submitter: Harald Kusch
Investigations: Further information collections on COVID-19
Studies: ZB MED – Informationszentrum Lebenswissenschaften
Assays: COVI-19 Übersicht
Crosslinl (URL) to Gitlab info site on COVID-19 (University Medical Center Göttingen, Department of Medical Informatics)
Creators: Harald Kusch, Theresa Bender, Christian Bauer
Submitter: Harald Kusch
Investigations: Further information collections on COVID-19
Studies: University Medical Center Göttingen
Assays: 1 hidden item
Abstract (Expand)
Authors: Julian Sass, Alexander Bartschke, Moritz Lehne, Andrea Essenwanger, Eugenia Rinaldi, Stefanie Rudolph, Kai Uwe Heitmann, Joerg Janne Vehreschild, Christof von Kalle, Sylvia Thun
Date Published: 29th Jul 2020
Publication Type: Journal
DOI: 10.1101/2020.07.27.20162636
Citation: medrxiv;2020.07.27.20162636v1,[Preprint]
Abstract
Authors: Zichen Wang, Amanda B Zheutlin, Yu-Han Kao, Kristin L Ayers, Susan J Gross, Patricia Kovatch, Sharon Nirenberg, Alexander W Charney, Girish N Nadkarni, Paul F O'Reilly, Allan C Just, Carol R Horowitz, Glenn Martin, Andrea D Branch, Benjamin S Glicksberg, Dennis S Charney, David L Reich, William K Oh, Eric E Schadt, Rong Chen, Li Li
Date Published: 4th May 2020
Publication Type: Misc
DOI: 10.1101/2020.04.28.20075788
Citation: medrxiv;2020.04.28.20075788v1,[Preprint]
Abstract (Expand)
Authors: G. Wichmann, M. Rosolowski, K. Krohn, M. Kreuz, A. Boehm, A. Reiche, U. Scharrer, D. Halama, J. Bertolini, U. Bauer, D. Holzinger, M. Pawlita, J. Hess, C. Engel, D. Hasenclever, M. Scholz, P. Ahnert, H. Kirsten, A. Hemprich, C. Wittekind, O. Herbarth, F. Horn, A. Dietz, M. Loeffler
Date Published: 15th Dec 2015
Publication Type: Journal
PubMed ID: 26095926
Citation: Int J Cancer. 2015 Dec 15;137(12):2846-57. doi: 10.1002/ijc.29649. Epub 2015 Jul 6.
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Martin Golebiewski
Submitter: Martin Golebiewski
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
The Research Data Alliance (RDA) is a volunteer community of over 10,500 professionals from 145 countries across the globe. In less than two months, the community responded to an urgent call for action and defined much needed, comprehensive recommendations and guidelines for data sharing under the present COVID-19 circumstances.
Creators: Martin Golebiewski, see full list of members of the RDA COVID-19 working group: https://www.rd-alliance.org/node/68704/members
Submitter: Martin Golebiewski
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
This is the fifth and final draft of the Recommendations and Guidelines from the RDA COVID-19 working group, and is open for public comment until 8th of June 2020. Following the open period, feedback will be considered and then the WG will seek endorsement of the document from the RDA governance bodies prior to final publication.
Creators: Martin Golebiewski, see full list of members of the RDA COVID-19 working group: https://www.rd-alliance.org/node/68704/members
Submitter: Martin Golebiewski
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Draft guidelines and recommendations; fourth release, 15 May 2020, version for public review
Creator: see full list of members of the RDA COVID-19 working group: https://www.rd-alliance.org/node/68704/members
Submitter: Martin Golebiewski
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Matthias Löbe
Submitter: Matthias Löbe
Investigations: Lean European Open Survey on SARS-CoV-2 Infecte...
Studies: LEOSS
Assays: LEOSS Clinical Document List
Creator: Matthias Löbe
Submitter: Matthias Löbe
Investigations: Lean European Open Survey on SARS-CoV-2 Infecte...
Studies: LEOSS
Assays: LEOSS Clinical Document List